Intelligent Ultrasound Group PLC GE Healthcare launches new ultrasound AI software (5145A)
September 30 2020 - 2:00AM
UK Regulatory
TIDMMED
RNS Number : 5145A
Intelligent Ultrasound Group PLC
30 September 2020
Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Company")
GE Healthcare launches new ultrasound AI software
GE Healthcare launches new Voluson SWIFT ultrasound system with
industry first auto recognition tools that incorporate the AI
technology of Intelligent Ultrasound
Intelligent Ultrasound (AIM: MED), the artificial intelligence
(AI) based ultrasound software and simulation company, today
announced that GE Healthcare has launched its new AI-enhanced
Women's Health ultrasound system, Voluson SWIFT*. The Voluson SWIFT
features SonoLyst, the world's first fully integrated AI tool that
recognizes the 20 views recommended by the International Society of
Ultrasound in Obstetrics and Gynaecology mid-trimester practice
guidelines for fetal imaging and incorporates Intelligent
Ultrasound's ScanNav Assist AI technology.
SonoLyst features two applications that leverage Intelligent
Ultrasound's technology, SonoLystIR and SonoLystX. SonoLystIR
performs automated detection of the key scanning views and
automated selection of the relevant Voluson SonoBiometry
measurement tools; and SonoLystX, a virtual on-board ultrasound
expert, uses AI to compare the acquired image to standardised
criteria, to ensure that it meets clinical standards. SonoLystX can
help enhance accuracy and quality and is ideal for teaching,
training and quality assurance to ensure the highest quality image
standards and consistency.
SonoLyst is the first AI software to be launched under the
Group's long-term licence and co-development agreement with GE
Healthcare that enables the integration of Intelligent Ultrasound's
real-time AI image analysis software into GE Healthcare's Voluson
women's health ultrasound portfolio. The first royalty per unit
revenues for Intelligent Ultrasound are expected at the start
2021.
* 510(k) currently pending at FDA. Not available for sale in the
United States.
Roland Rott, General Manager of Women's Health Ultrasound at GE
Healthcare, said:
"Voluson SWIFT has redefined one of the most essential tools
obstetrics and gynaecology clinicians rely on, delivering a
contemporary design, intuitive user interface, and intelligent
workflow supported by AI. In today's environment where cleanliness
and time saving opportunities are critical for clinicians, we're
proud to offer a solution that makes our customers' work easier and
gives them time back with their patients."
Prof Aris Papageorghiou, Professor of Fetal Medicine, St
George's Healthcare NHS Trust, London said:
"I have worked in the field of AI in ultrasound for over ten
years, yet I am still amazed at the level of accuracy that has been
achieved. You can really see how Intelligent Ultrasound's AI
technology, incorporated in the SonoLyst software, will improve
efficiency, make the learning of ultrasound easier and reduce
omissions and errors. It's a big advance for ultrasound imaging in
women's health."
Stuart Gall, CEO of Intelligent Ultrasound, said:
"It has been a pleasure to work with GE over the last year to
bring this new AI technology to market. The new Voluson SWIFT
ultrasound system uses radical innovations such as SonoLyst to
bring new levels of efficiency to obstetric ultrasound scanning. We
are excited about our continuing collaboration to bring the latest
AI solutions to the market and wish GE Healthcare every success
with what we think is the future of ultrasound scanning in women's
healthcare."
For further information, please contact:
Intelligent Ultrasound Group plc www. intelligentultrasound.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Cenkos Securities - Nominated Advisor Tel: +44 (0)20 7397 8900
and Broker
Giles Balleny / Cameron MacRitchie (Corporate
Finance)
Michael Johnson / Julian Morse (Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy / Paul McManus Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980
541 893
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: MED) develops artificial
intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market and hi-fidelity virtual
reality simulators for the ultrasound training market.
www.intelligentultrasound.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCEAANNAEDEEAA
(END) Dow Jones Newswires
September 30, 2020 02:00 ET (06:00 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024